It has been shown previously that the chance of achieving (partial) T2D remission is higher among persons with a shorter disease duration, lower age, and lower baseline HbA1c, who are not using insulin, and when pharmacological treatment is not yet initiated [43,44]. The gene discussed is INS; the disease is type 2 diabetes mellitus.